RecruitingPhase 1NCT05152394
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Naples, FL
Phase 1 Parkinson's Disease clinical trials
19 recruiting Phase 1 parkinson's disease studies in the US. What trial phases mean
Other phases
RecruitingPhase 1NCT06565195
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Sponsor: Prevail Therapeutics
Englewood, CO · New Haven, CT · Naples, FL · +4 more sites
RecruitingPhase 1NCT06809400
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Sponsor: Eli Lilly and Company
Los Alamitos, CA · Maitland, FL · +9 more sites
RecruitingPhase 1NCT07161414
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
Sponsor: AstraZeneca
Huntersville, NC · San Antonio, TX · Fairfax, VA
RecruitingPhase 1NCT04396873
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Sponsor: National Institute of Mental Health (NIMH)
Bethesda, MD
RecruitingPhase 1NCT06683365
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
Sponsor: Craig van Horne, MD, PhD
Lexington, KY
RecruitingPhase 1NCT06683378
A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery
Sponsor: Craig van Horne, MD, PhD
Lexington, KY
RecruitingPhase 1NCT06482268
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Sponsor: University of California, San Diego
La Jolla, CA
RecruitingPhase 1NCT07543861
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
Sponsor: University of Michigan
Ann Arbor, MI
RecruitingPhase 1NCT05142189
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Sponsor: BioNTech SE
Lexington, KY · Louisville, KY · Baltimore, MD · +3 more sites
RecruitingPhase 1NCT07557706
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 1NCT07422675
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Sponsor: Serina Therapeutics
Englewood, CO · Hallandale, FL · Maitland, FL · +1 more sites
RecruitingPhase 1NCT07064005
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
Sponsor: Pravat Mandal
Pittsburgh, PA
RecruitingPhase 1NCT06997484
First-in-Human Single and Multiple Dose of HL-400
Sponsor: Highlightll Pharmaceutical (USA) LLC
Baltimore, MD
RecruitingPhase 1NCT06687837
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
Sponsor: Jeffrey S. Schweitzer, MD, PhD
Boston, MA
RecruitingPhase 1NCT04246437
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Sponsor: Daniel Claassen
Nashville, TN
RecruitingPhase 1NCT02897063
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Not yet recruitingPhase 1NCT06647277
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Sponsor: ProgenaBiome
Ventura, CA
Not yet recruitingPhase 1NCT07267065
AAV2-hAADC for Parkinson's Disease (PDCS-01)
Sponsor: Krzysztof Bankiewicz
Columbus, OH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.